Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences (NYSE:EW) with a Neutral and raises the price target from $90 to $98.
Citigroup Maintains Neutral on Edwards Lifesciences, Raises Price Target to $98
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.